Sexual health problems in French cancer survivors 2 years after diagnosis—the national VICAN survey

Charif, Ali Ben; Bouhnik, Anne-Déborah; Courbière, Blandine; Rey, Dominique; Préau, Marie; Bendiane, Marc Karim; Peretti‐Watel, Patrick; Mancini, Julien

doi:10.1007/s11764-015-0506-3

Cited by 38 publications

(40 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…During informed consent, adverse effects that are common should be discussed [26]. Given the high prevalence and additional burden of sexual dysfunction after cancer treatment, sexual side effects of treatment should be part of informed consent [1][2][3][4][5]26]. Lack of knowledge, lack of time and lack of clarity about sexual side effects in current guidelines may result in ambiguity regarding responsibility for discussing sexual side effects [18].…”

Section: Discussionmentioning

confidence: 99%

“…All cancer therapies, including chemo-, hormonal-and immunotherapy, radiation and surgery can impair the sexual function. The prevalence of sexual side effects following therapy varies, depending on cancer and therapy type, but may even rise to 100% after treatment of genital cancers [1][2][3][4][5]. Cancer patients often face sexual symptoms from the start of treatment and these are likely to continue or even increase in the long term [6].…”

Section: Introductionmentioning

confidence: 99%

“…Patients reported unmet needs regarding discussing sexuality with their health care providers. While some patients wish to discuss this topic, they feel health care providers do not provide an opportunity to talk about sexual function or even ignore their sexual needs [ 5 , 11 , 12 , 15 – 17 ]. On the other hand, not all healthcare professionals consider it their task to discuss the subject [ 18 ].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Discussing Sexual Health in the Medical Oncologist’s Practice: Exploring Current Practice and Challenges

et al. 2019

View full text Add to dashboard Cite

Sexuality is a significant quality-of-life concern for many cancer patients. Patients may be disadvantaged if they are not informed and not offered sexual health care. We sought to reveal oncologists' current practice and opinions concerning sexual counselling. The aim of this study was to explore the knowledge, attitude and practice patterns of Dutch medical oncologists regarding treatment-related sexual dysfunction. Questionnaires were sent to 433 members of the Dutch Society of Medical Oncology. The majority (81.5%) of the 120 responding medical oncologists (response rate 30.6%) stated they discussed sexual function with fewer than half of their patients. At the same time, 75.8% of the participating oncologists agreed that addressing sexual function is their responsibility. Sexual function was discussed more often with younger patients and patients with a curative treatment intent. Barriers for avoiding discussing sexual function were lack of time (56.1%), training (49.5%) and advanced age of the patient (50.4%). More than half (64.6%) stated they had little knowledge about the subject and the majority (72.9%) wanted to acquire additional training in sexual function counselling. Medical oncologists accept that sexual function counselling falls within their profession, yet they admit to not counselling patients routinely concerning sexual function. Only in a minority of cases do medical oncologists inform their patients about sexual side effects of treatment. Whether they counsel patients is related to how they view patient's prognosis, patient's age, and self-reported knowledge. Findings indicate there is a role for developing education and practical training.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Discussing Sexual Health in the Medical Oncologist’s Practice: Exploring Current Practice and Challenges

et al. 2019

View full text Add to dashboard Cite

show abstract

“…Fertility preservation (FP) is a major determinant of quality of life after cancer remission for women who may not have completed their family or achieved their ideal family size [ 11 ].…”

Section: Introductionmentioning

confidence: 99%

Fertility preservation healthcare circuit and networks in cancer patients worldwide: what are the issues?

et al. 2018

View full text Add to dashboard Cite

BackgroundFertility preservation (FP) is a major determinant of quality of life after cancer remission for women who may not have achieved their ideal family size. This article describes the FP services and strategy currently available, highlighting issues of oncofertility worldwide.Main body of the abstractFor these patients in complex situations, health networks are essential to improve coordination of care, and the strengthening of this coordination is a major challenge to improve the performance of the health system. Two international networks have been created in order to foster scientific exchange between countries and to standardize the oncofertility healthcare circuit. However, the paucity of referral nationwide networks lead to a structural gap in health care policies.Short conclusionManagement strategies of oncofertility in the world are still fragile and uneven. To structure the oncofertility sector, a multidisciplinary project allowing teams to collaborate is of utmost importance particularly in low and middle-income countries.

show abstract

“…Cancer and its treatment can negatively affect sexuality and intimacy, resulting in a decreased quality of life of patients with cancer (Ben Charif et al, 2016a, 2016bBober and Varela 2012;Ussher, Perz, Gilbert, & Australian Cancer and Sexuality Study Team, 2015). Most partners of patients with cancer report a negative impact on their sexuality and intimacy as well (Garos, Kluck, & Aronoff, 2007;Gilbert, Perz, & Ussher, 2016;Hawkins et al, 2009;Lehto, Aromaa, & Tammela, 2018;Miaja, Platas, & Martinez-Cannon, 2017;Oldertroen Solli, de Boer, Solbraekke, & Thoresen, 2019).…”

Section: Introductionmentioning

confidence: 99%

Sexuality in Intimate Partners of People with Cancer: Information and Communication Needs: A Brief Communication

Albers

Belzen²,

Batenburg³

et al. 2020

Journal of Sex & Marital Therapy

View full text Add to dashboard Cite

Partners of patients with cancer report a negative impact on their sexuality and intimacy and experience a lack of information. Little is known about partners' information needs regarding sexuality and intimacy. The study was conducted with 230 partners of patients with cancer using a questionnaire. 56% stated that cancer had negatively affected their sexuality and intimacy. 60% percent reported a need for information. Except a selfreported negative impact of cancer, no characteristics were associated with a higher need for sexuality related information. Partners prefer information that includes practical advice and experiences from others. It is recommended to provide patients and their partner's information on sexuality and intimacy within routine treatment.

show abstract

Sexual health problems in French cancer survivors 2 years after diagnosis—the national VICAN survey

Abstract: Interventions aimed at improving sexual health irrespective of age and cancer site should be developed.

Cited by 38 publications

References 39 publications

Discussing Sexual Health in the Medical Oncologist’s Practice: Exploring Current Practice and Challenges

Discussing Sexual Health in the Medical Oncologist’s Practice: Exploring Current Practice and Challenges

Fertility preservation healthcare circuit and networks in cancer patients worldwide: what are the issues?

Sexuality in Intimate Partners of People with Cancer: Information and Communication Needs: A Brief Communication

Contact Info

Product

Resources

About